Financial Trading Blog

Stock of the day 03/02/2016 – The Coca-Cola Co




Can the company climb back to December’s 12 month highs with its fourth quarter figures next Tuesday?

From that $36.56 Black Monday nadir Coca-Cola had managed to rise back to $42.20 by the eve of its third quarter results in October. Those figures saw a worse-than-expected fall in revenue, dropping 5% to $11.4 billion thanks to the stronger dollar, with almost a third wiped off of the company’s net income, which slipped to $1.4 billion. Still drinks were the star of Coke’s quarter, sales rising 6% worldwide; the company’s namesake beverages (and the rest of the soda division), on the other hand, only rose 3%.

Coca Cola Chart February 2016
(Source: IT-Finance.com 03/02/2016)

Whilst the stock did see an initial bounce to $43.85 in the aftermath of its third quarter results, investors weren’t impressed for long, leading Coca-Cola to hit $41.45 by the middle of November. However, the company soon began to pick up speed, reaching $43.92 a month later, before entering 2016 at $42.34. The troubling trading of the New Year, however, continued to play havoc with Coke’s price, veering between lows of $40.76 and highs of $43.36; it sits a current trading price of $42.45 (IT-Finance.com, 03/02/2016).

It was revealed at the start of February that Coca-Cola managed to increase its global market share of the soda sector to 48.5% during 2015; whether this translate to an investor-impressing set of fourth quarter figures, however, is another matter. Still drinks will be the sector to watch, dominating as it has for the past few quarters, whilst investors will be keen to see if Coca-Cola has managed to mitigate the slowing growth in its soda division (something the company has attempted to achieve through offering its unhealthier drinks in smaller packaging). Then there are the macro-considerations, namely the stronger dollar and China’s economic slowdown, both of which took percentage points of the company’s growth in Q3.

The Coca-Cola Co has a consensus rating of ‘Hold’ with an average target price of $45.56.

DISCLAIMER


Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 64% of retail investors lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money. For professional clients, spread betting and CFD trading can also result in losses larger than your initial stake or deposit.

Spreadex Ltd is authorised and regulated by the Financial Conduct Authority, provides an execution only service and does not provide advice in any way. Nothing within this update should be deemed to constitute the provision of investment advice, recommendations, any other professional advice in any way, or a record of our trading prices. This update does not constitute or form part of an offer of, or solicitation for a transaction in any financial instrument, nor shall it or the fact of its distribution form the basis of, or be relied on in connection with, any contract therefore. Any persons placing trades based on their interpretation of the comments or information within this update does so entirely at their own risk.

No representation, warranty, or undertaking, express or limited, is given as to the accuracy or completeness of the information or opinions contained within this update by Spreadex Ltd or any of its employees and no liability is accepted by such persons for the accuracy or completeness of any such information or opinions. As such, no reliance may be placed for any purpose on the information and opinions contained within this update.

The information contained within this update is the intellectual property of Spreadex Ltd and is protected by UK and International copyright laws. All rights reserved. Users may however freely download, distribute and reproduce extracts of the contents, subject always to accrediting Spreadex Ltd as the source and providing a hyperlink to www.spreadex.com.